Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000513014 | SCV000528021 | benign | not provided | 2019-07-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000513014 | SCV000608790 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BP7 |
Invitae | RCV000513014 | SCV002469316 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002244909 | SCV002514339 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279193 | SCV002565233 | likely benign | Ehlers-Danlos syndrome | 2020-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402173 | SCV002708278 | benign | Cardiovascular phenotype | 2019-05-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |